[1]
Gugiatti, E. et al. 2017. A reversible carnitine palmitoyltransferase I (CPT1) inhibitor offsets chronic lymphocytic leukemia cell proliferation. Italian Journal of Anatomy and Embryology. 122, 1 (Oct. 2017), 108.